发明名称 PIPERIDINYL-AND PIPERAZINYL-SULFONYLMETHYL HYDROXAMIC ACIDS AND THEIR USE AS PROTEASE INHIBITORS
摘要 This invention is directed generally to proteinase (also known as "protease") inhibitors, and, more particularly, to piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids that, inter alia, inhibit matrix metalloproteinase (also known as "matrix metalloprotease" or "MMP") activity and/or aggrecanase activity. Such hydroxamic acids generally correspond in structure to formula (I); (wherein A<1>, A<2>, Y, E<1>, E<2>, E<3>, and R<x> are as defined in this specification), and further include salts of such compounds. This invention also is directed to compositions of such hydroxamic acids, intermediates for the syntheses of such hydroxamic acids, methods for making such hydroxamic acids, and methods for treating conditions (particularly pathological conditions) associated with MMP activity and/or aggrecanase activity.
申请公布号 WO2005042521(A3) 申请公布日期 2005.07.07
申请号 WO2004US36666 申请日期 2004.11.03
申请人 PHARMACIA CORPORATION;BROWN, DAVID, L.;GRAPPERHAUS, MARGARET, L.;KASSAB, DARREN, J.;MASSA, MARK, A.;MCDONALD, JOSEPH, J.;MULLINS, PATRICK, B.;RICO, JOSEPH, G.;SCHMIDT, MICHELLE, A. 发明人 BROWN, DAVID, L.;GRAPPERHAUS, MARGARET, L.;KASSAB, DARREN, J.;MASSA, MARK, A.;MCDONALD, JOSEPH, J.;MULLINS, PATRICK, B.;RICO, JOSEPH, G.;SCHMIDT, MICHELLE, A.
分类号 A61K31/452;C07D211/16;C07D211/22;C07D211/66;C07D211/96;C07D309/08;C07D401/06;C07D401/12;C07D401/14;C07D405/12;C07D405/14;C07D407/12;C07D409/12;C07D409/14;C07D413/12;C07D413/14;C07D417/12;C07D417/14 主分类号 A61K31/452
代理机构 代理人
主权项
地址